IBIObenzinga

Institutional Investors Exercise iBio Warrants At Reduced Exercise Price Of $1.11/Shr Resulting In Gross Proceeds Of About $6.2M

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 29, 2025 by benzinga